StemCells, Inc. to P
StemCells, Inc. to Present at Biotech Showcase 2012
09 janv. 2012 09h00 HE | StemCells, Inc.
NEWARK, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Anno
StemCells, Inc. Announces Closing of Public Offering of Common Stock and Warrants
22 déc. 2011 09h00 HE | StemCells, Inc.
NEWARK, Calif., Dec. 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has closed its previously announced underwritten offering of an aggregate of 8,000,000 units and...
StemCells, Inc. Anno
StemCells, Inc. Announces Pricing of Public Offering to Raise Up to $20 Million
16 déc. 2011 09h15 HE | StemCells, Inc.
NEWARK, Calif., Dec. 16, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the pricing of an underwritten public offering of an aggregate of 8,000,000 units and 8,000,000 Series B...
StemCells, Inc. Anno
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
15 déc. 2011 16h40 HE | StemCells, Inc.
NEWARK, Calif., Dec. 15, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in...
StemCells, Inc. Comp
StemCells, Inc. Completes Enrollment of First Cohort in Landmark Chronic Spinal Cord Injury Trial
15 déc. 2011 09h00 HE | StemCells, Inc.
NEWARK, Calif., Dec. 15, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the first cohort of the Company's Phase I/II clinical trial in chronic spinal cord injury have been...
StemCells, Inc. to P
StemCells, Inc. to Present at 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum
28 nov. 2011 16h05 HE | StemCells, Inc.
NEWARK, Calif., Nov. 28, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Prov
StemCells, Inc. Provides Business Update and Reports Third Quarter 2011 Financial Results
01 nov. 2011 16h05 HE | StemCells, Inc.
NEWARK, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Anno
StemCells, Inc. Announces Webcast to Discuss Third Quarter Financial Results and Business Update
27 oct. 2011 09h00 HE | StemCells, Inc.
NEWARK, Calif., Oct. 27, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to F
StemCells, Inc. to Feature at 2011 World Stem Cell Summit
28 sept. 2011 09h00 HE | StemCells, Inc.
NEWARK, Calif., Sept. 28, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that three of its senior executives and a key academic research collaborator are scheduled to present...
StemCells, Inc. CEO
StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter
23 sept. 2011 14h21 HE | StemCells, Inc.
NEWARK, Calif., Sept. 23, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its president and CEO, Martin McGlynn, is featured on the financial website...